In this study, we provided evidence showing that MSCs can be reprogrammed towards a pro-tumor phenotype by gastric cancer cells through an epigenetic mechanism, which involves increased IGF2BP2-mediated m6A modification and stability of CSF2 mRNA. The gene discussed is CSF2; the disease is gastric cancer.